ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
27.07
-0.32 (-1.17%)
Feb 21, 2025, 4:00 PM EST - Market closed
ArriVent BioPharma Market Cap
ArriVent BioPharma has a market cap or net worth of $912.18 million as of February 21, 2025. Its market cap has increased by 24.08% in one year.
Market Cap
912.18M
Enterprise Value
629.54M
1-Year Change
24.08%
Ranking
Category
Stock Price
$27.07
Market Cap Chart
Since the IPO on January 26, 2024, ArriVent BioPharma's market cap has increased from $575.22M to $912.18M, an increase of 58.58%. That is a compound annual growth rate of 53.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 912.18M | 1.61% |
| Dec 31, 2024 | 897.69M | 56.06% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |